United States Neutropenia Treatment Market Report 2017

August 2017 | 106 pages | ID: UBD593AF43CEN
QYResearch

Abstracts

In this report, the United States Neutropenia Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Neutropenia Treatment in these regions, from 2012 to 2022 (forecast).

United States Neutropenia Treatment market competition by top manufacturers/players, with Neutropenia Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen
• Novartis
• Teva Pharmaceutical
• Inc.
• Sanofi
• Novartis AG
• Baxter International
• Teva Pharmaceuticals Industries Ltd
• Apotex
• Dr. Reddy's Laboratory Ltd.
• Biogenomics Limited
• Intas Pharmaceuticals Ltd.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Antibiotic Therapy
• Colony-Stimulating Factor Therapy
• Granulocyte Transfusion
• Splenectomy Procedure
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Neutropenia Treatment for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Contents

United States Neutropenia Treatment Market Report 2017

1 NEUTROPENIA TREATMENT OVERVIEW

1.1 Product Overview and Scope of Neutropenia Treatment
1.2 Classification of Neutropenia Treatment by Product Category
  1.2.1 United States Neutropenia Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Neutropenia Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Antibiotic Therapy
  1.2.4 Colony-Stimulating Factor Therapy
  1.2.5 Granulocyte Transfusion
  1.2.6 Splenectomy Procedure
  1.2.7 Others
1.3 United States Neutropenia Treatment Market by Application/End Users
  1.3.1 United States Neutropenia Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 United States Neutropenia Treatment Market by Region
  1.4.1 United States Neutropenia Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Neutropenia Treatment Status and Prospect (2012-2022)
  1.4.3 Southwest Neutropenia Treatment Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Neutropenia Treatment Status and Prospect (2012-2022)
  1.4.5 New England Neutropenia Treatment Status and Prospect (2012-2022)
  1.4.6 The South Neutropenia Treatment Status and Prospect (2012-2022)
  1.4.7 The Midwest Neutropenia Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Neutropenia Treatment (2012-2022)
  1.5.1 United States Neutropenia Treatment Sales and Growth Rate (2012-2022)
  1.5.2 United States Neutropenia Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES NEUTROPENIA TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Neutropenia Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Neutropenia Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Neutropenia Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Neutropenia Treatment Market Competitive Situation and Trends
  2.4.1 United States Neutropenia Treatment Market Concentration Rate
  2.4.2 United States Neutropenia Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Neutropenia Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NEUTROPENIA TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Neutropenia Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Neutropenia Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Neutropenia Treatment Price by Region (2012-2017)

4 UNITED STATES NEUTROPENIA TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Neutropenia Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Neutropenia Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Neutropenia Treatment Price by Type (2012-2017)
4.4 United States Neutropenia Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NEUTROPENIA TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Neutropenia Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Neutropenia Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEUTROPENIA TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neutropenia Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.2 Neutropenia Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva Pharmaceutical
  6.3.2 Neutropenia Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Pharmaceutical Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Inc.
  6.4.2 Neutropenia Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Inc. Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Neutropenia Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis AG
  6.6.2 Neutropenia Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis AG Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Baxter International
  6.7.2 Neutropenia Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Baxter International Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceuticals Industries Ltd
  6.8.2 Neutropenia Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceuticals Industries Ltd Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Apotex
  6.9.2 Neutropenia Treatment Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Apotex Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Dr. Reddy's Laboratory Ltd.
  6.10.2 Neutropenia Treatment Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Dr. Reddy's Laboratory Ltd. Neutropenia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Biogenomics Limited
6.12 Intas Pharmaceuticals Ltd.

7 NEUTROPENIA TREATMENT MANUFACTURING COST ANALYSIS

7.1 Neutropenia Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neutropenia Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neutropenia Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neutropenia Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEUTROPENIA TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Neutropenia Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Neutropenia Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Neutropenia Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Neutropenia Treatment Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neutropenia Treatment
Figure United States Neutropenia Treatment Market Size (K Units) by Type (2012-2022)
Figure United States Neutropenia Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibiotic Therapy Product Picture
Figure Colony-Stimulating Factor Therapy Product Picture
Figure Granulocyte Transfusion Product Picture
Figure Splenectomy Procedure Product Picture
Figure Others Product Picture
Figure United States Neutropenia Treatment Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Neutropenia Treatment by Application in 2016
Figure Hospital Pharmacy Examples
Figure Retail Pharmacy Examples
Figure Online Pharmacy Examples
Figure United States Neutropenia Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Neutropenia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Neutropenia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Neutropenia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Neutropenia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Neutropenia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Neutropenia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neutropenia Treatment Sales (K Units) and Growth Rate (2012-2022)
Figure United States Neutropenia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neutropenia Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Neutropenia Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Neutropenia Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neutropenia Treatment Sales Share by Players/Suppliers
Figure 2017 United States Neutropenia Treatment Sales Share by Players/Suppliers
Figure United States Neutropenia Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Neutropenia Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Neutropenia Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neutropenia Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Neutropenia Treatment Revenue Share by Players/Suppliers
Table United States Market Neutropenia Treatment Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Neutropenia Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Neutropenia Treatment Market Share of Top 3 Players/Suppliers
Figure United States Neutropenia Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Neutropenia Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Neutropenia Treatment Product Category
Table United States Neutropenia Treatment Sales (K Units) by Region (2012-2017)
Table United States Neutropenia Treatment Sales Share by Region (2012-2017)
Figure United States Neutropenia Treatment Sales Share by Region (2012-2017)
Figure United States Neutropenia Treatment Sales Market Share by Region in 2016
Table United States Neutropenia Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Neutropenia Treatment Revenue Share by Region (2012-2017)
Figure United States Neutropenia Treatment Revenue Market Share by Region (2012-2017)
Figure United States Neutropenia Treatment Revenue Market Share by Region in 2016
Table United States Neutropenia Treatment Price (USD/Unit) by Region (2012-2017)
Table United States Neutropenia Treatment Sales (K Units) by Type (2012-2017)
Table United States Neutropenia Treatment Sales Share by Type (2012-2017)
Figure United States Neutropenia Treatment Sales Share by Type (2012-2017)
Figure United States Neutropenia Treatment Sales Market Share by Type in 2016
Table United States Neutropenia Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Neutropenia Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neutropenia Treatment by Type (2012-2017)
Figure Revenue Market Share of Neutropenia Treatment by Type in 2016
Table United States Neutropenia Treatment Price (USD/Unit) by Types (2012-2017)
Figure United States Neutropenia Treatment Sales Growth Rate by Type (2012-2017)
Table United States Neutropenia Treatment Sales (K Units) by Application (2012-2017)
Table United States Neutropenia Treatment Sales Market Share by Application (2012-2017)
Figure United States Neutropenia Treatment Sales Market Share by Application (2012-2017)
Figure United States Neutropenia Treatment Sales Market Share by Application in 2016
Table United States Neutropenia Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Neutropenia Treatment Sales Growth Rate by Application (2012-2017)
Table Amgen Basic Information List
Table Amgen Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Amgen Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Amgen Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Novartis Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Novartis Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Inc. Basic Information List
Table Inc. Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Inc. Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Inc. Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Inc. Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Sanofi Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Sanofi Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Novartis AG Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Novartis AG Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Baxter International Basic Information List
Table Baxter International Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter International Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Baxter International Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Baxter International Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceuticals Industries Ltd Basic Information List
Table Teva Pharmaceuticals Industries Ltd Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Apotex Basic Information List
Table Apotex Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Apotex Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Apotex Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Apotex Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Dr. Reddy's Laboratory Ltd. Basic Information List
Table Dr. Reddy's Laboratory Ltd. Neutropenia Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratory Ltd. Neutropenia Treatment Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratory Ltd. Neutropenia Treatment Sales Market Share in United States (2012-2017)
Figure Dr. Reddy's Laboratory Ltd. Neutropenia Treatment Revenue Market Share in United States (2012-2017)
Table Biogenomics Limited Basic Information List
Table Intas Pharmaceuticals Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neutropenia Treatment
Figure Manufacturing Process Analysis of Neutropenia Treatment
Figure Neutropenia Treatment Industrial Chain Analysis
Table Raw Materials Sources of Neutropenia Treatment Major Players/Suppliers in 2016
Table Major Buyers of Neutropenia Treatment
Table Distributors/Traders List
Figure United States Neutropenia Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Neutropenia Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Neutropenia Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Neutropenia Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Neutropenia Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Neutropenia Treatment Sales Volume (K Units) Forecast by Type in 2022
Table United States Neutropenia Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Neutropenia Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Neutropenia Treatment Sales Volume (K Units) Forecast by Application in 2022
Table United States Neutropenia Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Neutropenia Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neutropenia Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neutropenia Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources